| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.47 | 0.005 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.45 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.34 | 0.08 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |